Licensing Agreement

 

Panacea Pharmaceuticals, Inc. has licensed the worldwide (except USA) rights to HAAH tumor marker-based diagnostic laboratory services to Panacea Global, Inc. (PANG, OTC).  The terms included an upfront licensing fee and a significant portion of the stock in Panacea Global, Inc.  A supply and service agreement has also been signed to provide the HAAH diagnostic test reagents and technical support at a pre-negotiated fee.